Did the Treatment Advocacy Center actually uncover research proving that poor psychiatric medication adherence plays a "significant" role in whether people diagnosed with schizophrenia become violent? If such research does exist, is it as compelling as TAC described?
Clinicians play a key role in empowering adolescents and their parents to make decisions about their mental health treatment.
After telling my psychotherapist about my medication-fueled suicidal ideation, he said, “You have two options. We can do this either voluntarily or involuntarily.” Aghast and shaken, but assuming everyone in the medical system had my best interests at heart, I reluctantly agreed to go to the hospital without any protest.
At a recent conference on legal capacity, I was struck by the failure of another invited expert to adhere to the paradigm of supported decision-making as articulated by the CRPD Committee. We still need to work to ensure that this paradigm is well understood and appreciated, despite the progress made in national reforms.
Ethnographic research sheds light on extensive psychopharmaceutical use by soldiers in post 9/11 U.S. wars.
MIA's Peter Simons interviews David Cohen, PhD, on his path to researching mental health, coercive practices, and discontinuation from psychiatric drugs.
Researchers, publishing in Toxicology Research, review the evidence that antidepressant exposure in the womb is linked to autism spectrum disorders (ASD) in humans.
Research illustrates privacy concerns with how mental health applications collect and share users’ data.
A new meta-review examines the experiences of antipsychotic drugs use among people diagnosed with a psychotic disorder.
In all countries, we need to work for ensuring that forced medication for psychiatric patients is forbidden by law. Virtually all countries, apart from the US, have ratified the UN Convention on the Rights of Persons with Disabilities, which prohibits forced drugging, but not a single country has done anything.
Industry-funded continuing medical education (CME) influences physicians to prescribe more opioids, focus less on the consequences.
Researchers question biases of preliminary trials that found that sodium nitroprusside, an antihypertensive drug, has positive effects on schizophrenia symptoms.
New study finds that antidepressants may negatively impact recovery after psychiatric hospitalization.
Debate ensues as scholars and policymakers discuss how to bring a rights-based approach to mental health policy.
Twice as many teenagers with ADHD experienced severe psychosis when taking Adderall, as compared to Ritalin, according to a new study.
Peer-Support Groups Were Right, Guidelines Were Wrong: Dr. Mark Horowitz on Tapering Off Antidepressants
In an interview with MIA, Dr. Horowitz discusses his recent article on why tapering off antidepressants can take months or even years.
Researchers examine psychiatrist-client interactions and find that clients are often left with few opportunities to make explicit requests to change their medication regimen.
A new article in Lancet Psychiatry finds that slower tapering of SSRIs is better for preventing antidepressant withdrawal effects.
European citizens from 27 different countries will soon go to the polls to elect their representatives in the European Parliament for the next five years. As an advocacy organisation, we see those elections as an opportunity to call on current and future European leaders and policymakers to bring mental health to the heart of European policies.
A new analysis finds multiple antecedents of refugee prejudice, including religiousness, conservatism, and education.
Researchers explore pathways of healing racial trauma in Latinx immigrant communities.
Several members of the FDA Advisory Committee perceived this new drug as a potential “game changer” in the way depression is treated. I, however, am NOT one of them. I take my role as the Consumer Representative very seriously and want to make sure that any pharmaceutical drug that the FDA approves shows greater benefit than potential harm.
The researchers found that although antidepressants had a slight short-term effect on reducing the likelihood of depression diagnosis, there was no long-term improvement, nor any improvement in motor functioning.
New research points to numerous harmful effects of high-level lead exposure in childhood on adult mental health and personality characteristics.
“Converging lines of evidence now suggest that depression—a common comorbidity in the setting of chronic pain—may in some patients represent an unrecognized yet potentially reversible harm of opioid therapy.”